Jemperli

ASCO 2025: GSK’s Jemperli fails to show OS benefit in 1L advanced ovarian cancer
Clinical Trials Arena
Tue, 06/3/25 - 10:58 pm
ASCO 2025
GSK
Jemperli
clinical tirals
ovarian cancer
EU approves endometrial, lung cancer drugs from GSK and J&J
Pharmaphorum
Tue, 01/21/25 - 11:10 am
Eurioe
GSK
JNJ
endometrial cancer
lung cancer
Jemperli
Rybrevant
Lazcluze
GSK posts mixed survival data for Jemperli/Zejula combo in first-line ovarian cancer
BioSpace
Fri, 12/20/24 - 11:24 am
GSK
Jemperli
Zejula
clinical trials
ovarian cancer
GSK blows Jemperli marching brass against Keytruda with expanded FDA nod in endometrial cancer
Fierce Pharma
Thu, 08/1/24 - 11:19 pm
GSK
Jemperli
Merck
Keytruda
FDA
endometrial cancer
GSK’s Jemperli shows potential in Phase II trial for locally advanced rectal cancer
Clinical Trials Arena
Tue, 06/4/24 - 11:26 am
GSK
Jemperli
clinical trials
rectal cancer
GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data
BioSpace
Mon, 03/18/24 - 05:11 pm
GSK
Jemperli
endometrial cancer
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
GSK's cancer drug combination meets primary goal in late-stage trial
Reuters
Mon, 12/18/23 - 10:10 am
GSK
Zejula
Jemperli
endometrial cancer
clinical trials
GSK's Jemperli prolongs life in endometrial cancer trial. Will FDA label expansion come next?
Fierce Pharma
Mon, 10/30/23 - 10:12 am
GSK
Jemperli
endometrial cancer
clinical trials
ESMO: In PD-1 battle GSK waged on Merck, Jemperli appears to show survival edge over Keytruda in lung cancer
Fierce Pharma
Fri, 10/20/23 - 11:47 am
Merck
GSK
Keytruda
Jemperli
ESMO
nonsquamous non-small cell lung cancer
GSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancer
Fierce Pharma
Mon, 07/31/23 - 09:59 pm
GSK
FDA
immunotherapy
endometrial cancer
Jemperli
In new PD-1 showdown, GSK's Jemperli loses initial edge on Merck's Keytruda
Fierce Pharma
Mon, 03/27/23 - 10:09 pm
GSK
Merck
Keytruda
Jemperli
cancer
FDA assembles adcomm to review GSK's Jemperli trial plans in rectal cancer
Endpoints
Tue, 02/7/23 - 06:50 pm
FDA
GSK
rectal cancer
Jemperli
GSK Notches Phase III Win for Jemperli in Endometrial Cancer
BioSpace
Sun, 12/4/22 - 01:13 pm
GSK
Jemperli
clinical trials
endometrial cancer
GSK unveils Keytruda head-to-head data in lung cancer—and they look good at first glance
Fierce Pharma
Wed, 11/30/22 - 07:58 pm
GSK
Merck
Jemperli
Keytruda
clinical trials
non-small cell lung cancer
GSK’s “crown jewels” already look tarnished
EP Vantage
Wed, 11/23/22 - 07:27 am
GSK
Blenrep
Emma Walmsley
daprodustat
gepotidacin
otilimab
Jemperli
Zejula
cabotegravir
The mystery of Jemperli’s rectal cancer breakthrough
EP Vantage
Mon, 06/20/22 - 10:28 am
ASCO 2022
GSK
Jemperli
rectal cancer
GSK immunotherapy shows promise as alternative to surgery in certain rectal cancers
MedCity News
Fri, 06/10/22 - 10:34 am
GSK
Jemperli
rectal cancer
clinical trials
The biotech behind GlaxoSmithKline's PD-1 just scored a $250M cash deal for royalties
Endpoints
Tue, 10/26/21 - 10:46 am
AnaptysBio
Jemperli
GSK
GSK's Jemperli follows Merck's Keytruda with FDA nod to target certain tumors regardless of location
Fierce Pharma
Wed, 08/18/21 - 11:08 am
GSK
Jemperli
FDA
cancer
Merck
Keytruda

Pages